채용
Editas Medicine

Editas Medicine
Genome editing company
Gene Editing
CRISPR Technology
Genomic Medicine
Clinical Research
Rare Diseases
Open Positions
0 positions
No open positions at this time
Products & Services
RE
reni-cel
Gene Therapy
IN
In Vivo Gene Editing Medicines
Gene Therapy
Leadership
CS
Charlene Stern
Executive Vice President & General Counsel
KB
Kevin Bitterman
Interim President
DRL
David R. Liu
Founder
FZ
Feng Zhang
Founder
Similar Companies

Caribou Biosciences
Series C
CRISPR genome editing company
Berkeley, CA
201-500
7 open jobs

Illumina
Public
Unlocking the power of the genome.
San Diego, California
5,001-10,000
115 open jobs

Plus
Series A
Focused on the pharmacy distribution of drugs with a stated goal to lower the prices for generic drugs by removing middlemen, such as pharmacy bene...
Dallas, Texas
51-200

Anthem (Elevance)
Public
Health insurance company.
Indianapolis, Indiana
10,001+
157 open jobs

Kaiser Permanente
Public
Integrated healthcare organization
Oakland, California
10,001+

Insitro
Series C
Biotechnology company.
South San Francisco, CA
201-500
Valuation $2.4B
16 open jobs
News & Buzz
All
X
News
HN
YouTube
Editas Medicine, Inc. (NASDAQ:EDIT) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Source: MarketBeat
google-news
·
1mo ago
Individual investors who hold 55% of Editas Medicine, Inc. (NASDAQ:EDIT) gained 14%, institutions profited as well - simplywall.st
Source: simplywall.st
google-news
·
1mo ago
Editas Medicine Announces Third Quarter 2025 Results and Business Updates - GlobeNewswire
Source: GlobeNewswire
google-news
·
3mo ago
Editas Medicine: Three Strikes And It's Out, Or Third Time’s The Charm? - Seeking Alpha
Source: Seeking Alpha
google-news
·
4mo ago
Editas Medicine Inc. (EDIT) Confirms EDT-401 as Lead Vivo Program - Yahoo Finance
Source: Yahoo Finance
google-news
·
5mo ago
More (6 remaining)
Total Views
0
Apply Clicks
0
Mock Applicants
0
Scraps
0
Reviews
3.5
8 reviews
Work Life Balance
3.8
Compensation
3.5
Culture
3.2
Career
2.8
Management
2.3
Pros
Good benefits and compensation
Positive work environment
Interesting science and work
Cons
Poor upper management
Lack of direction and strategy changes
Management issues and poor leadership
Salary Ranges
38 data points
Director
Director
1 reports
$195,000
total / year
Base
$150,000
Stock
-
$195,000
$195,000
Interview Experience
39 interviews
Difficulty
3.4
/ 5
Duration
2-5w
Offer Rate
35%
Experience
Positive 67%
Neutral 15%
Negative 18%
Interview Process
1
Phone Screen
2
Technical Interview
3
Hiring Manager
4
Team Fit
Contact & Location